Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.2145
+0.0075 (3.62%)
At close: Mar 6, 2026, 4:00 PM EST
0.2157
+0.0012 (0.56%)
After-hours: Mar 6, 2026, 6:52 PM EST
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $1.59 million as of March 6, 2026. Its market cap has decreased by -79.85% in one year.
Market Cap
1.59M
Enterprise Value
-1.31M
1-Year Change
-79.85%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $1.59M, a decrease of -99.23%. That is a compound annual growth rate of -73.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.59M | -37.97% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 2.62M |
| Artelo Biosciences | 2.59M |
| XORTX Therapeutics | 2.55M |
| Adial Pharmaceuticals | 2.30M |
| Bone Biologics | 2.26M |
| Lyra Therapeutics | 2.25M |
| Azitra | 2.09M |
| Ensysce Biosciences | 2.06M |